Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 3
2017 7
2018 4
2019 1
2020 4
2021 7
2022 8
2023 5
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Deferiprone in Parkinson's Disease.
Devos D, Labreuche J, Rascol O, Corvol JC, Duhamel A, Guyon Delannoy P, Poewe W, Compta Y, Pavese N, Růžička E, Dušek P, Post B, Bloem BR, Berg D, Maetzler W, Otto M, Habert MO, Lehericy S, Ferreira J, Dodel R, Tranchant C, Eusebio A, Thobois S, Marques AR, Meissner WG, Ory-Magne F, Walter U, de Bie RMA, Gago M, Vilas D, Kulisevsky J, Januario C, Coelho MVS, Behnke S, Worth P, Seppi K, Ouk T, Potey C, Leclercq C, Viard R, Kuchcinski G, Lopes R, Pruvo JP, Pigny P, Garçon G, Simonin O, Carpentier J, Rolland AS, Nyholm D, Scherfler C, Mangin JF, Chupin M, Bordet R, Dexter DT, Fradette C, Spino M, Tricta F, Ayton S, Bush AI, Devedjian JC, Duce JA, Cabantchik I, Defebvre L, Deplanque D, Moreau C; FAIRPARK-II Study Group. Devos D, et al. N Engl J Med. 2022 Dec 1;387(22):2045-2055. doi: 10.1056/NEJMoa2209254. N Engl J Med. 2022. PMID: 36449420 Clinical Trial.
Mapping neurotransmitter systems to the structural and functional organization of the human neocortex.
Hansen JY, Shafiei G, Markello RD, Smart K, Cox SML, Nørgaard M, Beliveau V, Wu Y, Gallezot JD, Aumont É, Servaes S, Scala SG, DuBois JM, Wainstein G, Bezgin G, Funck T, Schmitz TW, Spreng RN, Galovic M, Koepp MJ, Duncan JS, Coles JP, Fryer TD, Aigbirhio FI, McGinnity CJ, Hammers A, Soucy JP, Baillet S, Guimond S, Hietala J, Bedard MA, Leyton M, Kobayashi E, Rosa-Neto P, Ganz M, Knudsen GM, Palomero-Gallagher N, Shine JM, Carson RE, Tuominen L, Dagher A, Misic B. Hansen JY, et al. Among authors: beliveau v. Nat Neurosci. 2022 Nov;25(11):1569-1581. doi: 10.1038/s41593-022-01186-3. Epub 2022 Oct 27. Nat Neurosci. 2022. PMID: 36303070 Free PMC article.
HFP-QSMGAN: QSM from homodyne-filtered phase images.
Beliveau V, Birkl C, Stefani A, Gizewski ER, Scherfler C. Beliveau V, et al. Magn Reson Med. 2022 Sep;88(3):1255-1262. doi: 10.1002/mrm.29260. Epub 2022 Apr 5. Magn Reson Med. 2022. PMID: 35381109 Free PMC article.
Effects of escitalopram on synaptic density in the healthy human brain: a randomized controlled trial.
Johansen A, Armand S, Plavén-Sigray P, Nasser A, Ozenne B, Petersen IN, Keller SH, Madsen J, Beliveau V, Møller K, Vassilieva A, Langley C, Svarer C, Stenbæk DS, Sahakian BJ, Knudsen GM. Johansen A, et al. Among authors: beliveau v. Mol Psychiatry. 2023 Oct;28(10):4272-4279. doi: 10.1038/s41380-023-02285-8. Epub 2023 Oct 9. Mol Psychiatry. 2023. PMID: 37814129 Free PMC article. Clinical Trial.
Neurodegeneration in Hepatic and Neurologic Wilson's Disease.
Viveiros A, Beliveau V, Panzer M, Schaefer B, Glodny B, Henninger B, Tilg H, Zoller H, Scherfler C. Viveiros A, et al. Among authors: beliveau v. Hepatology. 2021 Aug;74(2):1117-1120. doi: 10.1002/hep.31681. Epub 2021 May 6. Hepatology. 2021. PMID: 33316133 Free PMC article.
Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma.
Iglseder S, Iglseder A, Beliveau V, Heugenhauser J, Gizewski ER, Kerschbaumer J, Stockhammer G, Uprimny C, Virgolini I, Dudas J, Nevinny-Stickel M, Nowosielski M, Scherfler C. Iglseder S, et al. Among authors: beliveau v. J Neurooncol. 2023 Sep;164(3):711-720. doi: 10.1007/s11060-023-04414-3. Epub 2023 Sep 14. J Neurooncol. 2023. PMID: 37707754 Free PMC article.
Long-Term Medication Profiles in Parkinson's Disease under Subthalamic Deep Brain Stimulation: A Controlled Study.
Theyer C, Beliveau V, Krismer F, Peball M, Mair K, Heim B, Djamshidian A, Kiechl S, Eisner W, Eschlböck S, Wenning GK, Willeit P, Seppi K, Poewe W, Mahlknecht P. Theyer C, et al. Among authors: beliveau v. Mov Disord Clin Pract. 2024 Jul;11(7):855-860. doi: 10.1002/mdc3.14065. Epub 2024 May 7. Mov Disord Clin Pract. 2024. PMID: 38715209 Free PMC article.
38 results